A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus
Clinical trial NCT03170518 · COMPLETED
Trial details
- NCT number
- NCT03170518
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-21
- Primary completion
- 2023-09-20
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.